Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 11
Submit an article Journal homepage
39
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Dose-intensified CHOP (Double-CHOP) Followed by Consolidation with High-dose Chemotherapy for High and High-intermediate Risk Aggressive Non-Hodgkin's Lymphomas

Tetsuo Yamazaki First Department of Internal Medicine, Nihon University School of Medicine, 30-1 Oyaguchikami-cho, Itabashi-ku, Tokyo 173-8610, Japan
,
Umihiko Sawada First Department of Internal Medicine, Nihon University School of Medicine, 30-1 Oyaguchikami-cho, Itabashi-ku, Tokyo 173-8610, Japan
,
Yoshimasa Kura First Department of Internal Medicine, Nihon University School of Medicine, 30-1 Oyaguchikami-cho, Itabashi-ku, Tokyo 173-8610, Japan
,
Takeyoshi Ito First Department of Internal Medicine, Nihon University School of Medicine, 30-1 Oyaguchikami-cho, Itabashi-ku, Tokyo 173-8610, Japan
,
Yoshitaka Kaneita First Department of Internal Medicine, Nihon University School of Medicine, 30-1 Oyaguchikami-cho, Itabashi-ku, Tokyo 173-8610, Japan
,
Kiyotaka Yasukawa First Department of Internal Medicine, Nihon University School of Medicine, 30-1 Oyaguchikami-cho, Itabashi-ku, Tokyo 173-8610, Japan
&
Takashi Horie First Department of Internal Medicine, Nihon University School of Medicine, 30-1 Oyaguchikami-cho, Itabashi-ku, Tokyo 173-8610, Japan
 show all
Pages 2117-2123 | Published online: 01 Jul 2009

  • Fisher, R.I., Gaynor, E.R., Dahlberg, S., Oken, M.M., Grogan, T.M., Mize, E.M., Glick, J.H., Coltman, C.A., Jr. and Miller, T.P. (1993) "Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma", New England Journal Medicine 328, 1002-1006.
  • Shipp, M.A., Abeloff, M.D., Antman, K.H., Carroll, G., Hagenbeek, A., Loeffler, M., Montserrat, E., Radford, J.A., Salles, G., Schmitz, N., Symann, M., Armitage, J.O., Philip, T. and Coiffier, B. (1999) "International consensus conference on high-dose therapy with hematopoietic stem cell transplantation in aggressive Non-Hodgkin's lymphoma: report of the jury", Journal of Clinical Oncology 17, 423-429.
  • The International Non-Hodgkin's Lymphoma Prognostic Factors Project (1993) "A predictive model for aggressive non-Hodgkin's lymphoma", New England Journal Medicine 329, 987-993.
  • Haioun, C., Lepage, E., Gissellbrecht, C., Bastion, Y., Coiffier, B., Brice, P., Bosly, A., Dupriez, B., Nouvel, C., Tilly, H., Lederlin, P., Briere, J., Gaulard, P. and Reyes, F. (1997) "Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated result of the prospective study LNH87-2", Journal of Clinical Oncology 15, 1131-1137.
  • Nademanee, A., Molina, A., O'Donnell, M.R., Dagis, A., Snyder, D.S., Parker, P., Stein, A., Smith, E., Planas, I., Kashyap, A., Spielberger, R., Fung, H., Wong, K.K., Somlo, G., Margolin, K., Chow, W., Sniecinski, I., Vore, N., Blume, K.G., Niland, J. and Forman, S.J. (1997) "Result of high-dose therapy and autologous bone marrow stem cell transplantation during remission in poor-risk intermediate and high-grade lymphoma: international index high and high-intermediate risk group", Blood 90, 3844-3852.
  • Harris, N.J., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K.C., Cleary, M.L., Delsol, G., Wolf-Peeters, C.D., Falini, B., Gatter, K.C., Grogan, T.M., Isaacson, P.O., Knowles, D.M., Mason, D.Y., Muller-Harmelink, H., Pileri, S.A., Piris, M.A., Ralfkiaer, E. and Warnke, A. (1994) "A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group", Blood 84, 1361-1392.
  • Freedmen, A.S., Tacvorian, T., Neuberg, D., Mauch, P. Rabinowe, S.N., Anderson, K.C., Soiffer, R.J., Spector, N., Grossbard, M., Robertson, M.J., Blake, K., Coral, K. Canellos, G.P., Ritz, J. and Nadler, L.M. (1993) "Autologous bone marrow transplantation in poor-prognosis intermediate-grade and high-grade B cell non-Hodgkin's lymphoma in first remission: a pilot study", Journal of Clinical Oncology 11, 931-936.
  • Waits, T.M., Greco, F.A., Greer, J.P., Johnson, D.H., Wolff, S.N., Stein, R.S., McMaster, M.L. and Hainsworth, J.D. (1999) "Effective therapy for poor-prognosis non-Hodgkin's lymphoma with 8 weeks of high-dose-intensity combination chermotherapy", Journal of Clinical Oncology 11, 943-949.
  • Stoppa, A.M., Bouabdallah, R., Chabannon, C., Novakovitch, G., Vey, N., Camerlo, J., Blaise, D., Xerri, L., Resbeut, M., Di Stefano, D., Burdou, V.J., Gastaut, J.A. and Maraninchi, D. (1997) "Intensive sequential chemotherapy with repeated blood stem cell support for untreated poor-prognosis non-Hodgkin's lymphoma", Journal of Clinical Oncology 15, 1722-1729.
  • Stahel, R.A., Jost, L.M., Kroner, T., Dommann-Scherrer, C., Maurer, R., Glanzmann, C. Jacky, E., Pichen, G., Pestalozzi, B., Marincek, B., Sauter, C. and Honegger, H. (1999) "A prospective study of risk-adopted therapy for large cell non-Hodgkin's lymphoma with VACOP-B followed by high-dose CBV and autologous progenitor cell transplantation for high-risk patients in remission", British Journal of Haematology 104, 763-769.
  • Shipp, M.A., Neuberg, D., Janicck, M., Cancellos, G.P. and Shulman, L.N. (1995) "High-dose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin's lymphoma: a dose-finding pilot study", Journal of Clinical Oncology 13, 2916-2923.
  • Jauntnen, E., Mahlamaki, E. and Nousiainen, T. (2000) "Feasibility and toxicity of high-dose chemotherapy supported by peripheral blood stem cell transplantation in elderly patients (? 60 years) with non-Hodgkin's lymphoma: comparison with patients < 60 years treated within the same protocol", Bone Marrow Transplantation 26, 731-741.
  • Freedman, A., Neubelg, D., Mauch, P., Gribben, J., Soiffer, R., Anderson, K., Robertson, M., Fisher, D.C., Schlossman, R., Kroon, M., Rhuda, C., Kuhlman, C., Jerome, R. and Nadler, L. (1997) "Cyclophosphamide, doxorubicin, vincristine, prednisone dose intensification with granulocyte colony-stimulation factor markedly depletes stem cell reserve for autologous bone marrow transplantation", Blood 90, 4996-5001.
  • Santini, G., Salvagno, L., Leoni, P., Chisesi, T., De Souza, C., Sertoli, M.R., Rubagotti, A., Congiu, A.M., Centurioni, R., Olivieri, A., Tedeschi, L., Vespignani, M., Nati, S., Soracco, M., Porcellini, A., Contu, A., Guarnaccia, C., Pescosta, N., Majolino, I., Spriano, M., Vimercati, R., Rossi, E., Zambaldi, G., Mangoni, L., Endrizzt, L., Sileni, V.C., Miggiano, M.C., Marino, G., Damasio, E. and Rizzoli, V. (1998) "VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the Non-Hodgkin's Lymphoran Cooperative Study Group", Journal of Clinical Oncology 16, 2796-2802.
  • Dumontet, C. Thieblemont, C., Epinouse, D., Bouatia, F., Hequet, O., Salles, G. and Coiffier, B. (2000) "A prospective study of intensive induction therapy with high-dose consolidation in patients with aggressive non-Hodgkin's lymphoma and two or three adverse prognostic factors", Leukemia 14, 2159-2165.
  • Bouabdallah, R., Stoppa, A.M., Coso, D., Bardou, V.J., Blaise, D., Chabannon, C., Gastaut, J.A. and Maraninchi, D (2001) "Clinical outcome after front-line intensive chemotherapy (ISC) in patients with aggressive non-Hodgkin's lymphoma and high-risk international prognostic index (IP13): final analysis of survival in two consecutive ISC trials", Annals of Oncology 12, 513-517.
  • For the Non-Hodgkin's lymphoma classification project Armitage. J.O. and Weisenburger, D.D. (1998) "New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes", Journal of Clinical Oncology 16, 1780-1795.
  • Moreau, P., Milpied, N., Voillat, L., Coiombat, P., Mahe, B., Rapp, M.J., Moreau, A., Dupas, B., Bulabois, C.E., Jude-Morineau, N. and Harousseau, J.L. (1998) "Peripheral blood stem cell transplantation as front-line therapy in patients aged 61 to 65 years: a pilot study", Bone Marrow Transplantation 21, 1193-1196.
  • Krishman, A., Bhatia, S., Slovak, M.L., Arber, D.A., Niland, J.C., Nademanee, A., Fung, H. Bhatia, R., Kashyap, P., Molina, A., O'Donnell, M.R., Parker, P.A., Sniecinski, I., Snyder, D.S., Spielberger, R., Stein, A. and Forman, S.J. (2000) "Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors", Blood 95, 1588-1593.
  • Coiffier, B., Lepage, E., Briere, J., Herbrecht, R., Tilly, H., Bouabdallah, R., Morel, P., Van Den Neste, E., Salles, G. Gaulard, P., Reyes, F., Lederlin, P. and Gisselbrecht, C. (2002) "CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma", New England Journal of Medicine 346, 235-242.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.